Cfm Oskar Tropitzsch GmbH


Cfm Oskar Tropitzsch GmbH assists the chemical, pharmaceutical and biotechnological industry in sourcing and producing chemical specialties. The core of our work is to supply the product which our customer is looking for - with the right documentation, the correct quantity from mg to mt and proper quality and this not only for a one shot business but to support projects from RnD state up to commercial production. To achieve these challenging goals Cfm Oskar Tropitzsch GmbH uses its excellent knowhow and worldwide network of qualified suppliers. Our product portfolio covers everything from ADCs to excipients to metals and metal compounds to pharmaceutical raw materials.

Regarding herbal ingredients, our portfolio ranges from reference standards and phytochemicals to herbal extracts. We also offer medicinal plants from nearly all over the world with harvest protocol, ID- certification and/or Herbarium.

Finding the best solution! ...it's not just a sentence - it's our mission!

PhytoLab GmbH & Co. KG


Safety in Laboratory and Regulatory Services for Herbal Products: PhytoLab is an independent, accredited and officially recognised service laboratory for herbal products. Analysis, development, quality control and regulatory affairs of herbal medicinal products, food and cosmetics are our strengths. 

As one of the leading manufacturers internationally, PhytoLab offers a broad portfolio of over 1,340 extensively documented herbal reference substances. Our product range reflects the whole diversity of the chemistry of natural substances – from A as in absinthin to Z as in ziyuglycoside, PhytoLab offers you numerous representatives of all classes of natural substances. Within our range, you will also find the herbal reference substances listed in the monographs of the American, Chinese or European pharmacopoeias.

Bruker China


How Bruker has been driven by the idea to always provide the best technological solution for each analytical task for more than 55 years now 

Bruker enables scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, productivity and customer success in life science molecular research, in applied and pharma applications, and in microscopy, nano-analysis and industrial applications. In recent years, Bruker has also become a provider of high-performance systems for cell biology, preclinical imaging, clinical phenomics and proteomics research, clinical microbiology, and for molecular pathology research. 

Today, worldwide more than 6,000 employees are working on this permanent challenge at over 90 locations on all continents. Bruker continues to build upon its extensive range of products and solutions, its broad base of installed systems and a strong reputation among its customers. Being one of the world's leading analytical instrumentation companies, Bruker is strongly committed to further fully meet its customers’ needs as well as to continue to develop state-of-the-art technologies and innovative solutions for today's analytical questions.

Merck Chemicals (Shanghai) Co.,Ltd


Merck is a leading science and technology company in healthcare, life science and performance materials. Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Healthcare, EMD Millipore and EMD Performance Materials.

Agilent Technologies


Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics and applied chemical markets.With more than 50 years of insight and innovation,Agilentinstruments, software, services, solutions,andpeople provide trusted answers to its customers’ most challenging questions. The company generated revenues of $4.20 billion in fiscal 2016 and employs about 13,000 people worldwide. Information about Agilent is available at www.agilent.com.

Shanghai Standard Technology Co., Ltd.


Nature Standard is a leading company focusing on basic research and development of Traditional Chinese Medicine (TCM, herbs), other natural products, reference chemicals (including plant extracts with superb purity and authentic herbs), and related technical services. We provide technical services to worldwide customers in pharmaceutical, food and beverage, and cosmetic industries, including separation and manufacturing of components from TCM, basic research on TCM, reference standards of TCM, extraction technology development, and registration of TCM. 

Currently (2018) we provide more than 2,000 natural chemicals, among which about 500 have met the China national requirements for standard materials, and have been certified as reference standards for research and related works. In addition, based on the integration of retention times, UV spectra, and multi-stage mass spectrometry by LC-DAD-MSn, and in the collaboration with Agilent, we have established a high resolution data library for commercial natural products. This library can be used for rapid and accurate quantitative analyses of complex components in TCM, and it is an important tool for basic research and secondary development of TCM.

We look forward to your partnership.

Chengdu Biopurify Ltd.


Chengdu Biopurify Ltd. is a leading company in the research, development, manufacture and marketing of High Quality Phytochemicals and Extracts(especially Active Ingredients from Traditional Chinese Medicine,TCM), Natural Active Pharmaceutical Ingredients worldwide. From small quantities for R&D or reference standard, to large quantities for customizing or manufacturing, Biopurify emphasizes on consistent and reliable services for his customers. 
With excellent quality products and good service, we have clients from more than dozens countries and regions, and we pride ourselves in providing our customers with a total satisfaction experiences.
We are doing our best to be your reliable partner for high quality Phytochemicals and Reference Standards from china.

Our main services:
 A. Supply active ingredients and reference standards of TCM, from mgs to kgs scale.
 B. Custom extraction and purification, target Herb Active Ingredients
 C. Custom synthesis and semi-synthesis for Natural Active Ingredients
 D. CR, CM and PD services from lab scale, pilot scale to commercial scale(GMP is also available)
 E. TCM compounds library


China Resources Saike Pharmaceutical Co, Ltd (Formerly known as Beijing Saike Pharmaceutical Co., Ltd. , Beijing Second Pharmaceutical Factory, hereinafter referred to as “CRSP”), is a wholly-owned subsidiary of China Resources Double-Crane Pharmaceutical Co., Ltd. (hereinafter referred to as “CR Double-Crane”, 600062) , which directly owned by the Chinese central government. It is a pharmaceutical company with a sound capability of R&D, API manufacturing, finished dosage manufacturing and commercial distribution.

A Brief review of the Internationalization Progress of CRSP:
In 1984, API facility passed US FDA's site inspections for the first time.
In 2004-2009, Initiated internationalization project, obtained EU GMP certification, EU EHS certification, US FDA cGMP certification.
In 2011, obtained ANDA approval of amlodipine tablet.
In 2012-2013, Isoniazid API was officially included in the WHO anti-tuberculosis procurement catalogue. In 2014, Formulation facility passed FDA PAI site inspection API facility obtain WHO PQ certification. 
We have more than eight brand generic drugs distributed in China market, among which Amlodipine, Valsartan, Finasteride and Terazosin were the in-house key products, while Fragmin®, Sermion® and Nitrostat® were agent products.

Pharmaceutical product in-licensing with business model of repackaging and distributing is one of CRSP's outstanding product pipeline development strategies. With well-established hospital promotion and distribution platforms and a new version Eu GMP and US cGMP-compliant finished dosage facility, we can offer our partners a one-stop solution from product registration, product launching, commercialization, and distribution in the Chinese pharmaceutical market.

Nanjing  Sanhome Pharmaceutical Co. Ltd.,


Sanhome Pharmaceutical Co. Ltd., an innovative medicine enterprise with over ten kinds of drugs such as “Xiao’aiping” injection getting award of Military Prize for Progress in Science and Technology, has the sixth chemical innovation drug in Chinese history, i.e. “Younuoan” (left-handed ornidazole sodium chloride injection) which is one of the only two chemical innovation drugs authorized during “the Eleventh Five-year ”.

There are over 2000 staffs at present, including over 87% employees with bachelor degree or above, among which about 300 employees have doctor or master degree.

About 0.2 billion of patients have benefited from Sanhome products since establishment in 1996.

Chengdu Push Bio-Technology Co., Ltd.


Chengdu Push Bio-Technology Co., Ltd. (Stock short name: Push Bio-Technology; Stock code: 832791) is a professional leading company specialized in the R&D and manufacture of High Quality Active Ingredients from Traditional Chinese Medicine in China. We provide more than 3000 natural monomeric substances separated and purified from over than 150 plants in different grades, specifications and purities to meet your needs in many fields. 

With excellent quality products and good service, we have cooperated with over 1000 colleges, organizations, research institutions and companies more than 80 countries all over the world. including some famous large companies, some well-known European and American universities and research institutions, such as Sigma, Chromadex, EDQM, Extrasynthese, CP and etc.

Our Main services
1. Construct high-quality natural product library for drug research and development. More than 3000 compounds are available, many of them are our unique products.
2. Provide reference substances and active components of Traditional Chinese Medicine.
3. Provide more products of inhibitors in addition to a variety of screening libraries.
4. Provide isolation and structure determination of natural products.
5. Custom-R&D and manufacturing service for reference substances of Chinese herbs.

Shandong Danhong Pharmaceutical Co., Ltd.


On the basis of the Theory of NaoXinTongZhi, three exclusive patent varieties: NaoxinTong, Wenxin Granule, Danhong Injection were developed, including stroke, arrhythmia, insufficiency of blood supply and ischemic infarction, and so on. Among them, Shandong Danhong Pharmaceutical Co., Ltd. is a company specializing in the production of GMP certified injections. At present, the company can produce capsules, granules, injections and many other dosage forms. In the near future, will lay out the large health industry, and still base on Patented Chinese Traditional Medicine, and actively develop biological pharmaceuticals, and internet medicine (mobile medical, wear medical, e-commerce and so on). With the strong and rising of China, Buchang Pharmaceuticals Co. will further deepen the global layout through the merger and acquisition of products and companies to the modernization of Chinese Traditional Medicine to the world-class.


SZYY Group Pharmaceutical Limited


Jiangsu Suzhong Pharmaceutical Group, founded in 1972, is a large pharmaceutical industry group with the development of China's pharmaceutical industry, in line with international pharmaceutical standards, and with a high starting point. The headquarters of the group is located in the Suzhou Pharmaceutical Industry Park of Taizhou City, Jiangsu Province, with Jiangsu Suzhong Pharmaceutical Group Co., Ltd as the core, and Jiangsu Suzhongxin Pharmaceutical Co., Ltd., Nanjing Suzhong Pharmaceutical Research Institute. Taizhou Pharmaceutical Co., Ltd. and other six holding companies, total assets of 1 billion yuan, the existing staff of more than 3000 people, all kinds of scientific and technological management personnel accounted for more than 50%. Companies in the field of natural drugs, chemical drugs, marine drugs and biological life In recent years, the company's performance has increased by more than 40% per year, and the comprehensive index ranks among the top 100 pharmaceutical enterprises in China.

Chia Tai Tianqing Pharmaceutical Group Co. Ltd


Chia Tai Tianqing Pharmaceutical Group Co. Ltd is a collection of scientific research, production and sales for the integration of innovative pharmaceutical group enterprise, is the domestic well-known liver health drug research and development and production base, as a key national high-tech enterprise, national torch plan lianyungang new medicine industry base key leading enterprise, enterprise of pharmaceutical industry in China in 2016 list of 16 (released) ranked by China's pharmaceutical industry information center.


SPH Shenxiang Health Medicine Co.,Ltd.


SHANGHAI SPH SHEN XIANG HEALTH CO.LTD is a wholly-owned subsidiary of SPH. To ensure its advantages in the whole industry chain ginseng health care products produce business, it is its main business to ensure the quality of farm and the quality of processing and products. As a well-known company franchise in high-grade ginseng tonic in Shanghai, the company have products such as Wild ginseng, Cordyceps sinensis, Dendrobium Feng Dou, sea cucumber, donkey-hide gelatin, American ginseng, velvet, white fungus. Among them , wild ginseng, Cordyceps sinensis, and American ginseng in our company have a huge influence in the market of Shanghai Chinese traditional medicine industry . 

 Waters Corporation


For fifty years, Waters Corp. has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.

Waters Corp., a publicly traded corporation (NYSE:WAT) headquartered in Milford, Massachusetts, holds worldwide leading positions in complementary analytical technologies - liquid chromatography, mass spectrometry, rheometry and microcalorimetry.  These markets account for approximately $5.0 billion of the estimated $20 - $25 billion worldwide analytical instrumentation market.

Specifically, the company designs, manufactures, sells and services ultra performance liquid chromatography (UPLC), high performance liquid chromatography (HPLC), chromatography columns and chemistry products, mass spectrometry (MS) systems, thermal analysis and rheometry instruments. 

Waters Corp. operates in two divisions: Waters Division and TA Instruments.